Enterprise AI Agent Adoption Grows, but Outcomes Remain Unproven

UBS reportedly has 12,700 AI agents in use across 608 live use cases, with more than 1,090 applications in development and live use cases up 81% year over year. Clinisys has announced a governed laboratory-AI roadmap, but availability is pending readiness reviews and benefits remain unproven. New vertical workflow examples, including mortgage file preparation, rely on company claims or anecdotes rather than independent outcome evidence.